Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cytosorbents ( (CTSO) ) just unveiled an announcement.
CytoSorbents Corporation announced a rights offering, providing eligible stockholders and warrantholders the chance to purchase units consisting of common stock and warrants at a set price. This financial move could intrigue investors looking to expand their holdings, especially with the oversubscription privilege allowing for additional unit purchases. However, investors should act promptly as the rights and potential ownership stakes will expire without value if not exercised by January 10, 2025.
For an in-depth examination of CTSO stock, go to TipRanks’ Stock Analysis page.
